(Q48693524)
English
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo
scientific article published on 11 April 2011
Statements
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo (English)
Ulrich Germing
Carlo Aul
Aristoteles Giagounidis
Uwe Platzbecker
Petra Muus
Stefan Suciu
Michael Lübbert
Liliana Baila
Björn Hans Rüter
Dominik Selleslag
Boris Labar
Helmut R Salih
Filip Beeldens
Karl-Heinz Pflüger
Corneel Coens
Anne Hagemeijer
Hans Eckart Schaefer
Arnold Ganser
Theo de Witte
Pierre W Wijermans
11 April 2011
29
15
1987-1996